Ascarids, commonly known as roundworms, represent one of the most important parasites affecting young horses, with Parascaris equorum (recently reclassified by some authorities as Parascaris univalens) being the primary species of concern. These large nematode parasites can reach impressive lengths of fifteen to fifty centimeters, making them among the largest internal parasites encountered in equine practice. While adult horses typically develop effective immunity that limits ascarid infections, foals and young horses up to approximately two to three years of age are highly susceptible to potentially heavy burdens that can cause serious clinical disease, including life-threatening intestinal obstruction.
Ascarid infection follows a complex life cycle involving larval migration through the liver and lungs before adult worms establish in the small intestine. This hepatopulmonary migration phase can produce respiratory signs in heavily infected young horses, while the intestinal phase causes the most significant clinical problems including ill-thrift, poor growth, and acute intestinal obstruction. The condition's significance lies not only in direct pathological effects but also in growing concerns about anthelmintic resistance in ascarid populations, challenging traditional deworming approaches and requiring more sophisticated management strategies.
The prevalence and impact of ascarid infection varies considerably based on management practices, with well-managed breeding operations implementing targeted control programs experiencing fewer clinical cases than operations without strategic parasite management. Foals acquire infection through ingesting highly environmentally resistant eggs from contaminated pastures, paddocks, and stabling areas. Environments where foals are raised year after year accumulate substantial egg contamination, creating conditions for ongoing transmission. The remarkable environmental persistence of ascarid eggs, which can remain viable for years in suitable conditions, contributes to the challenge of controlling this parasite.
Effective ascarid management in modern equine practice requires understanding parasite biology, age-specific vulnerability patterns, treatment options and their limitations, and the concerning reality of anthelmintic resistance. Strategic deworming programs targeting young horses during their vulnerable period, combined with environmental management to reduce egg contamination, form the basis of successful control. Early recognition of clinical ascarid disease enables prompt treatment that can prevent serious complications, while awareness of resistance patterns guides appropriate drug selection. This balance of prevention, monitoring, and appropriate treatment optimizes outcomes for young horses facing this ubiquitous parasitic threat.
